Study finds smoking related to subset of colorectal cancers

Smoking puts older women at significant risk for loss of DNA repair proteins that are critical for defending against development of some colorectal cancers, according to research from a team led by Mayo Clinic scientists.

In a study being presented at the annual meeting of the American Association for Cancer Research (AACR), the researchers found that women who smoked were at increased risk for developing colorectal tumors that lacked some or all of four proteins, known as DNA mismatch repair (MMR) proteins. These proteins keep cells lining the colon and rectum healthy because they recognize and repair genetic damage as well as mistakes that occur during cell division.

Researchers believe that, in this study population, few if any of the four proteins were absent because of an inherited genetic alteration. “We think that smoking induces a condition within intestinal cells that does not allow MMR genes to express their associated proteins, and this loss leads to formation of tumors in some women,” says the study’s lead author, Mayo gastroenterologist Paul Limburg, M.D.

The researchers also discovered a direct association between the number of cigarettes smoked daily by study participants and increased risk of developing these specific tumors. They say many previous studies have found only a very weak positive association between use of cigarettes and development of the cancer.

“Our findings suggest that tumors may form because cells can’t repair themselves from damage induced by smoking,” Dr. Limburg says. “Tobacco toxins appear to block the DNA repair genes from producing their beneficial proteins.

“We are beginning to realize that there might be different risk factors for different subsets of colon and rectal cancers. Smoking is emerging as a potentially important, modifiable risk factor among postmenopausal women,” he says.

The findings also could have other clinical implications with respect to chemotherapy, as tumors that lack MMR proteins might respond differently to standard treatment regimens, Dr. Limburg says.

The research team examined data from the 41,836-participant Iowa Women’s Health Study and selected those 1,421 women who developed colorectal cancer since the study began in 1986. They then worked with the Iowa Cancer Registry and pathology laboratories around the state to collect tumor specimens from these patients. To date, they have retrieved about 50 percent of the samples. This study, a first analysis, includes 432 samples, or about 30 percent of the group.

They analyzed the tumors for presence of four DNA mismatch repair proteins known to be active in cells lining the colon and rectum. Samples that had all four were labeled MMR-positive. Tumors with less than four were tagged as MMR-negative.

The researchers then correlated information reported by the patients on whether they had ever smoked and how many cigarettes they used daily with MMR protein patterns in their tumors.

They found that smoking status was not significantly associated with development of colorectal cancer in the 432 patients in general. However, when the scientists examined colorectal cancers in women smokers with the perspective of MMR-deficient gene involvement, there was a strong association between smoking and MMR-negative status. For example, former smokers had a 61 percent increase in relative risk for MMR-negative colorectal cancer compared to never smokers, and “current” smokers were more than twice as likely to develop colorectal tumors with absent mismatch repair proteins.

The association between smoking and MMR-negative colorectal cancer also steadily increased with the number of cigarettes a woman smoked per day, Dr. Limburg says. The relative risk for MMR-negative cancer increased 54 percent if a patient smoked 1–19 cigarettes daily, more than twofold for 20 cigarettes a day, and more than threefold for a woman who smoked more than 30 cigarettes daily.

He adds that the link between smoking with loss of MMR proteins and development of colorectal cancer may also occur in male smokers and in younger people, but that the researchers can’t make such associations because this study used data only from older women.

Source: Mayo Clinic

Related stories:

'One-hit' event provides new opportunity for colon cancer prevention, say Fox Chase researchers
More than 30 years ago, Alfred Knudson Jr., M.D., Ph.D., revolutionized the field of cancer genetics by showing that a person must lose both their paternal and maternal copies of a particular class of cancer-inhibiting genes, called tumor-suppressor genes, in order to develop cancer. This theory, called the two-hit hypothesis, guided scientists around the globe in their quest for tumor suppressor genes.
Researchers identify cancer-causing gene in many colon cancers
Demonstrating that despite the large number of cancer-causing genes already identified, many more remain to be found, scientists at Dana-Farber Cancer Institute have linked a previously unsuspected gene, CDK8, to colon cancer.
Scientists discover new link in pathway to cancer: hope for drug design
(PhysOrg.com) -- University of Manchester scientists have identified an exciting connection between a cell’s extracellular environment and the activity of a signalling pathway molecule that controls the development of organs and tissues, as well as cancer and kidney disease.
Different type of colon cancer vaccine reduces disease spread, Jefferson scientists show
(Taking advantage of the fact that the intestines have a separate immune system from the rest of the body, scientists at the Kimmel Cancer Center at Jefferson in Philadelphia have found a way to immunize mice against the development of metastatic disease.
Lack of CHFR gene expression sets stage for breast cancer
U-M study lays groundwork for better ways to choose effective treatments, provides insights on other cancers
A University of Michigan study reveals in detail how breast cells produce new cells that are predisposed to become cancerous, unless they receive the protective action of the CHFR gene.
The APCs of nerve cell function
Rapid information processing in the nervous system requires synapses, specialized contact sites between nerve cells and their targets. One particular synapse type, cholinergic, uses the chemical transmitter acetylcholine to communicate between nerve cells. Cholinergic synapses are essential for normal learning and memory, arousal, attention, and all autonomic (involuntary) nervous system functions. Malfunction of cholinergic synapses is implicated in Alzheimer's disease, age-related hearing loss, autonomic neuropathies, and certain forms of epilepsy and schizophrenia. Despite the importance of cholinergic synapses for cognitive and autonomic functions, little is known about the mechanisms that direct their assembly during development.
Researchers identify genetic markers that predict efficacy of novel cancer drug
Researchers at the University of Southern California (USC) and USC/Norris Comprehensive Cancer Center have identified genetic markers in cancer cells that predicted the benefit of a novel cancer drug prior to chemotherapy.
Fighting cancer before tumor grows
Researchers in Heidelberg have discovered a new strategy for an immunization against certain forms of cancer. They have determined that immune cells react strongly to the modified proteins in tumor cells in which a DNA repair defect has occurred. It is estimated that this repair defect is present in some 15 percent of all tumours.

News discussion:

Medicine & Health news